UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 136

Sortiert nach

Prevention and management of secondary central nervous system lymphoma

Haematologica (Roma), 2023-03, Vol.108 (3), p.673

2023

Volltextzugriff (PDF)

Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma

BMC cancer, 2022-09, Vol.22 (1), p.971-9, Article 971

2022

Volltextzugriff (PDF)

Differentiating central nervous system infection from disease infiltration in hematological malignancy

Scientific reports, 2022-09, Vol.12 (1), p.15805-15805, Article 15805

2022

Volltextzugriff (PDF)

Author Correction: Differentiating central nervous system infection from disease infiltration in hematological malignancy

Scientific reports, 2022-12, Vol.12 (1), p.21009-21009, Article 21009

2022

Volltextzugriff (PDF)

Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era: a retrospective study by the EBMT Lymphoma Working Party

Bone marrow transplantation (Basingstoke), 2019-10, Vol.54 (10), p.1625-1631

2019

Volltextzugriff (PDF)

Rituximab in primary central nervous system lymphoma—A systematic review and meta‐analysis

Hematological oncology, 2019-12, Vol.37 (5), p.548-557

2019

Volltextzugriff (PDF)

Management of primary and secondary CNS lymphoma

Hematological oncology, 2023-06, Vol.41 (S1), p.25-35

2023

Volltextzugriff (PDF)

EXABS-231-ABCL The Treatment of Primary and Secondary CNS Lymphoma

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S119-S122

2023

Volltextzugriff (PDF)

A retrospective study of MYC rearranged diffuse large B-cell lymphoma in the context of the new WHO and ICC classifications

Blood cancer journal (New York), 2023-04, Vol.13 (1), p.54-54, Article 54

2023

Volltextzugriff (PDF)

Early MRI Predictors of Relapse in Primary Central Nervous System Lymphoma Treated with MATRix Immunochemotherapy

Journal of personalized medicine, 2023-07, Vol.13 (7), p.1182

2023

Volltextzugriff (PDF)

How I treat secondary CNS involvement by aggressive lymphomas

Blood, 2023-11, Vol.142 (21), p.1771

2023

Volltextzugriff (PDF)

The JAK3-selective inhibitor PF-956980 reverses the resistance to cytotoxic agents induced by interleukin-4 treatment of chronic lymphocytic leukemia cells: potential for reversal of cytoprotection by the microenvironment

Blood, 2010-11, Vol.116 (22), p.4569-4577

2010

Volltextzugriff (PDF)

Autologous Stem-Cell Transplantation in Patients With HIV-Related Lymphoma

Journal of clinical oncology, 2009-05, Vol.27 (13), p.2192-2198

2009

Volltextzugriff (PDF)

Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow‐up

HemaSphere, 2024-06, Vol.8 (6), p.e89-n/a

2024

Volltextzugriff (PDF)

Filtration-Histogram Based Magnetic Resonance Texture Analysis (MRTA) for the Distinction of Primary Central Nervous System Lymphoma and Glioblastoma

Journal of personalized medicine, 2021-08, Vol.11 (9), p.876

2021

Volltextzugriff (PDF)

S101: OMISSION OF RADIOTHERAPY IN PRIMARY MEDIASTINAL B‐CELL LYMPHOMA PATIENTS FOLLOWING COMPLETE METABOLIC RESPONSE TO STANDARD IMMUNOCHEMOTHERAPY: RESULTS OF THE IELSG37 RANDOMISED TRIAL (NCT01599559)

HemaSphere, 2023-08, Vol.7 (S3), p.e2454568-n/a

2023

Volltextzugriff (PDF)

P015: Real World Escalated BEACOPDac Delivers Similar Outcomes to Escalated BEACOPP While Potentially Reducing Haematopoietic and Reproductive Toxicity

HemaSphere, 2022-10, Vol.6 (Suppl), p.7-8

2022

Volltextzugriff (PDF)

‘CARMEN’: is less, more? Lessons from trials in human immunodeficiency virus‐Burkitt lymphoma (HIV‐BL)

British journal of haematology, 2021-01, Vol.192 (1), p.13-14

2021

Volltextzugriff (PDF)

Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia

Blood, 2000-10, Vol.96 (8), p.2712-2716

2000

Volltextzugriff (PDF)

CNS prophylaxis in aggressive B-cell lymphoma

Hematology, 2022-12, Vol.2022 (1), p.138

2022

Volltextzugriff (PDF)

Controversies in central nervous system prophylaxis of high-risk diffuse large B-cell lymphoma

Current opinion in oncology, 2023-09, Vol.35 (5), p.382

2023

Volltextzugriff (PDF)

Guidelines for the management of diffuse large B‐cell lymphoma

British journal of haematology, 2016-07, Vol.174 (1), p.43-56

2016

Volltextzugriff (PDF)

Early detection of BCR-ABL transcripts by quantitative reverse transcriptase–polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia

Blood, 2001-03, Vol.97 (6), p.1560-1565

2001

Volltextzugriff (PDF)

The prevention of central nervous system relapse in diffuse large B‐cell lymphoma: a British Society for Haematology good practice paper

British journal of haematology, 2020-09, Vol.190 (5), p.708-714

2020

Volltextzugriff (PDF)

1 – 25 von 136

Suche als RSS-Feed

Aktive Filter

KollektionTaylor & Francis:Master (3349 titles)

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(129)
Mit Volltextzugriff
(125)

Publikationsform

Sprache

Englisch
(136)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(71)
Life Sciences & Biomedicine
(70)
Humans
(64)
Hematology
(53)
Lymphoma
(22)
Male
(19)
Female
(18)
Middle Aged
(18)
Oncology
(18)
Adult
(17)
Biological And Medical Sciences
(16)
Medical Sciences
(16)
Chemotherapy
(13)
Prognosis
(13)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(12)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(12)
Central Nervous System Neoplasms - Drug Therapy
(12)
Hematologic And Hematopoietic Diseases
(12)
Retrospective Studies
(12)
Rituximab
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Prevention and management of secondary central nervous system lymphoma

International multicenter retrospective analysis of thiotepa-based autologous stem cell transplantation for secondary central nervous system lymphoma

Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma

Differentiating central nervous system infection from disease infiltration in hematological malignancy

Author Correction: Differentiating central nervous system infection from disease infiltration in hematological malignancy

Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era: a retrospective study by the EBMT Lymphoma Working Party

Rituximab in primary central nervous system lymphoma—A systematic review and meta‐analysis

Management of primary and secondary CNS lymphoma

EXABS-231-ABCL The Treatment of Primary and Secondary CNS Lymphoma

A retrospective study of MYC rearranged diffuse large B-cell lymphoma in the context of the new WHO and ICC classifications

Early MRI Predictors of Relapse in Primary Central Nervous System Lymphoma Treated with MATRix Immunochemotherapy

How I treat secondary CNS involvement by aggressive lymphomas

The JAK3-selective inhibitor PF-956980 reverses the resistance to cytotoxic agents induced by interleukin-4 treatment of chronic lymphocytic leukemia cells: potential for reversal of cytoprotection by the microenvironment

Autologous Stem-Cell Transplantation in Patients With HIV-Related Lymphoma

Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow‐up

Filtration-Histogram Based Magnetic Resonance Texture Analysis (MRTA) for the Distinction of Primary Central Nervous System Lymphoma and Glioblastoma

S101: OMISSION OF RADIOTHERAPY IN PRIMARY MEDIASTINAL B‐CELL LYMPHOMA PATIENTS FOLLOWING COMPLETE METABOLIC RESPONSE TO STANDARD IMMUNOCHEMOTHERAPY: RESULTS OF THE IELSG37 RANDOMISED TRIAL (NCT01599559)

P015: Real World Escalated BEACOPDac Delivers Similar Outcomes to Escalated BEACOPP While Potentially Reducing Haematopoietic and Reproductive Toxicity

‘CARMEN’: is less, more? Lessons from trials in human immunodeficiency virus‐Burkitt lymphoma (HIV‐BL)

Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia

CNS prophylaxis in aggressive B-cell lymphoma

Controversies in central nervous system prophylaxis of high-risk diffuse large B-cell lymphoma

Guidelines for the management of diffuse large B‐cell lymphoma

Early detection of BCR-ABL transcripts by quantitative reverse transcriptase–polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia

The prevention of central nervous system relapse in diffuse large B‐cell lymphoma: a British Society for Haematology good practice paper

Aktive Filter

Suchergebnisse filtern